TWI806758B - 管理層析柱床支架的裝置和系統及相關方法 - Google Patents
管理層析柱床支架的裝置和系統及相關方法 Download PDFInfo
- Publication number
- TWI806758B TWI806758B TW111133769A TW111133769A TWI806758B TW I806758 B TWI806758 B TW I806758B TW 111133769 A TW111133769 A TW 111133769A TW 111133769 A TW111133769 A TW 111133769A TW I806758 B TWI806758 B TW I806758B
- Authority
- TW
- Taiwan
- Prior art keywords
- column
- chromatography
- housing
- bed
- bed support
- Prior art date
Links
- 238000004587 chromatography analysis Methods 0.000 title claims abstract description 127
- 238000000034 method Methods 0.000 title claims abstract description 49
- -1 polyethylene Polymers 0.000 claims description 11
- 239000004698 Polyethylene Substances 0.000 claims description 9
- 229920000573 polyethylene Polymers 0.000 claims description 9
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 238000005192 partition Methods 0.000 claims 2
- 238000003860 storage Methods 0.000 abstract description 19
- 239000000463 material Substances 0.000 description 52
- 229910052751 metal Inorganic materials 0.000 description 25
- 239000002184 metal Substances 0.000 description 25
- 239000000825 pharmaceutical preparation Substances 0.000 description 19
- 125000006850 spacer group Chemical group 0.000 description 18
- 229940126534 drug product Drugs 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 16
- 229920000642 polymer Polymers 0.000 description 13
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 12
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 238000003780 insertion Methods 0.000 description 10
- 230000037431 insertion Effects 0.000 description 10
- 230000005526 G1 to G0 transition Effects 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 8
- 150000002739 metals Chemical class 0.000 description 8
- 230000003014 reinforcing effect Effects 0.000 description 8
- 229960000074 biopharmaceutical Drugs 0.000 description 7
- 229920001684 low density polyethylene Polymers 0.000 description 7
- 239000004702 low-density polyethylene Substances 0.000 description 7
- 230000002787 reinforcement Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 229910000831 Steel Inorganic materials 0.000 description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 6
- 229910052759 nickel Inorganic materials 0.000 description 6
- 238000012856 packing Methods 0.000 description 6
- 239000010959 steel Substances 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- 229910052719 titanium Inorganic materials 0.000 description 6
- 229910045601 alloy Inorganic materials 0.000 description 5
- 239000000956 alloy Substances 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 239000003124 biologic agent Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 231100000053 low toxicity Toxicity 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002982 water resistant material Substances 0.000 description 2
- HMLGSIZOMSVISS-ONJSNURVSA-N (7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(C=C)CSC21)C(O)=O)=O)C(=O)\C(=N/OCOC(=O)C(C)(C)C)C1=CSC(N)=N1 HMLGSIZOMSVISS-ONJSNURVSA-N 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- 108010057186 Insulin Glargine Proteins 0.000 description 1
- COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
- 108010005716 Interferon beta-1a Proteins 0.000 description 1
- 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 1
- 108700021006 Interleukin-1 receptor antagonist Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 229960003697 abatacept Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960002964 adalimumab Drugs 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 229960002833 aflibercept Drugs 0.000 description 1
- 108010081667 aflibercept Proteins 0.000 description 1
- 229960004539 alirocumab Drugs 0.000 description 1
- 229960004238 anakinra Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003115 certolizumab pegol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229950003468 dupilumab Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229960000403 etanercept Drugs 0.000 description 1
- 229960002027 evolocumab Drugs 0.000 description 1
- 230000004399 eye closure Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 239000013016 formulated drug substance Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229960001743 golimumab Drugs 0.000 description 1
- 229960000598 infliximab Drugs 0.000 description 1
- 229960002869 insulin glargine Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960004461 interferon beta-1a Drugs 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012434 mixed-mode chromatography Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000011107 packed bed chromatography Methods 0.000 description 1
- HQQSBEDKMRHYME-UHFFFAOYSA-N pefloxacin mesylate Chemical compound [H+].CS([O-])(=O)=O.C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCN(C)CC1 HQQSBEDKMRHYME-UHFFFAOYSA-N 0.000 description 1
- 108010044644 pegfilgrastim Proteins 0.000 description 1
- 229960001373 pegfilgrastim Drugs 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229960003876 ranibizumab Drugs 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 229960004641 rituximab Drugs 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 229950006348 sarilumab Drugs 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229960003989 tocilizumab Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960000575 trastuzumab Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
- G01N30/6052—Construction of the column body
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
- G01N30/6047—Construction of the column with supporting means; Holders
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/22—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the construction of the column
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762598091P | 2017-12-13 | 2017-12-13 | |
| US62/598,091 | 2017-12-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202300207A TW202300207A (zh) | 2023-01-01 |
| TWI806758B true TWI806758B (zh) | 2023-06-21 |
Family
ID=64734167
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW111133769A TWI806758B (zh) | 2017-12-13 | 2018-12-05 | 管理層析柱床支架的裝置和系統及相關方法 |
| TW107143541A TWI791073B (zh) | 2017-12-13 | 2018-12-05 | 管理層析柱床支架的裝置和系統及相關方法 |
| TW112118374A TWI864762B (zh) | 2017-12-13 | 2018-12-05 | 管理層析柱床支架的裝置和系統及相關方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW107143541A TWI791073B (zh) | 2017-12-13 | 2018-12-05 | 管理層析柱床支架的裝置和系統及相關方法 |
| TW112118374A TWI864762B (zh) | 2017-12-13 | 2018-12-05 | 管理層析柱床支架的裝置和系統及相關方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US11460452B2 (enExample) |
| EP (1) | EP3724653B1 (enExample) |
| JP (3) | JP7171724B2 (enExample) |
| KR (2) | KR102751947B1 (enExample) |
| CN (2) | CN117405806A (enExample) |
| AR (2) | AR113632A1 (enExample) |
| AU (2) | AU2018385394B2 (enExample) |
| CA (1) | CA3084155A1 (enExample) |
| EA (1) | EA039731B1 (enExample) |
| IL (4) | IL313285B2 (enExample) |
| MX (3) | MX2020005699A (enExample) |
| SG (1) | SG11202005154VA (enExample) |
| TW (3) | TWI806758B (enExample) |
| WO (1) | WO2019118187A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117405806A (zh) * | 2017-12-13 | 2024-01-16 | 里珍纳龙药品有限公司 | 管理层析柱床支架的装置和系统及相关方法 |
| WO2026121023A1 (ja) * | 2024-12-03 | 2026-06-11 | 株式会社島津製作所 | カラム保護カバー及びガスクロマトグラフ装置 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120279034A1 (en) * | 2009-12-17 | 2012-11-08 | Ge Healthcare Bio-Sciences Ab | Chromatography column and maintenance method |
| CN104307207A (zh) * | 2013-12-17 | 2015-01-28 | 长沙市源创精科生物技术有限公司 | 一种全自动层析柱 |
| CN104364645A (zh) * | 2012-06-21 | 2015-02-18 | 通用电气健康护理生物科学股份公司 | 色谱柱和对色谱柱进行维护的方法 |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU746281A1 (ru) | 1978-04-07 | 1980-07-07 | Ордена Трудового Красного Знамени Специальное Конструкторское Бюро Аналитического Приборостроения Научно-Технического Объединения Ан Ссср | Колонка дл жидкостной хроматографии |
| US5107908A (en) * | 1989-05-03 | 1992-04-28 | Analytical Bio-Chemistry Laboratories, Inc. | Apparatus for supporting a container for fluid material |
| GB2248027A (en) * | 1990-09-19 | 1992-03-25 | Amicon Ltd | End cell for chromatography column. |
| US5219216A (en) * | 1991-08-08 | 1993-06-15 | Microcomputer Accessories, Inc. | Hanging diskette storage cabinet |
| GB2344543B (en) | 1998-12-10 | 2002-11-27 | Millipore Corp | Chromatography column system and method of packing a chromatography system |
| US7303746B2 (en) | 1999-06-08 | 2007-12-04 | Regeneron Pharmaceuticals, Inc. | Methods of treating eye disorders with modified chimeric polypeptides |
| CN101433715B (zh) * | 1999-06-08 | 2013-04-17 | 里珍纳龙药品有限公司 | 具有改善的药物动力学特性的修饰嵌合多肽 |
| US7306799B2 (en) | 1999-06-08 | 2007-12-11 | Regeneron Pharmaceuticals, Inc. | Use of VEGF inhibitors for treatment of eye disorders |
| US7087411B2 (en) | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| US7070959B1 (en) | 1999-06-08 | 2006-07-04 | Regeneron Pharmaceuticals, Inc. | Modified chimeric polypeptides with improved pharmacokinetic properties |
| US7048133B2 (en) * | 2001-04-23 | 2006-05-23 | Black & Decker Inc. | Storage container |
| US20030029939A1 (en) * | 2001-08-08 | 2003-02-13 | Mykrolis Corp | No drip valve |
| US9114383B2 (en) | 2003-07-14 | 2015-08-25 | Phynexus, Inc. | Method and device for extracting an analyte |
| CN1886814B (zh) * | 2003-12-03 | 2010-04-07 | 松下电器产业株式会社 | 硬币形蓄电部件 |
| EP1877438A2 (en) | 2005-02-02 | 2008-01-16 | Regeneron Pharmaceuticals, Inc. | Method of treating eye injury with local administration of a vegf inhibitor |
| US20070023303A1 (en) * | 2005-07-27 | 2007-02-01 | Garry Templeton | Packaging |
| CA2654510C (en) | 2006-06-16 | 2015-03-17 | Regeneron Pharmaceuticals, Inc. | Vegf antagonist formulations suitable for intravitreal administration |
| JP4376919B2 (ja) | 2007-03-23 | 2009-12-02 | 株式会社日立ハイテクノロジーズ | 分離カラム及びそれを用いた液体クロマトグラフ装置 |
| US20100155275A1 (en) * | 2007-05-25 | 2010-06-24 | Meadwestvaco Corporation | Packages for holding compact discs |
| US7780853B2 (en) | 2007-06-15 | 2010-08-24 | Ge Healthcare Bio-Sciences Ab | Method for conducting maintenance on a chromatography column |
| US20100219115A1 (en) * | 2007-06-27 | 2010-09-02 | Ge Healthcare Biosciences Corp. | System and method for assembling a large scale chromatography structure |
| JP4973507B2 (ja) * | 2008-01-08 | 2012-07-11 | 栗田工業株式会社 | クロマトグラフィ装置およびクロマトグラフィ装置の制御装置 |
| CN201201776Y (zh) * | 2008-05-08 | 2009-03-04 | 王颜琦 | 轴承包装盒 |
| WO2010024760A1 (en) * | 2008-08-27 | 2010-03-04 | Ge Healthcare Bioscience Bioprocess Corp. | A system and method for manufacturing bed supports for chromatography columns |
| US11219844B2 (en) * | 2010-01-25 | 2022-01-11 | Spf Technologies Llc | Stackable planar adsorptive devices |
| US9950277B2 (en) * | 2010-06-03 | 2018-04-24 | Ge Healthcare Bioprocess R&D Ab | Parallel assembly of chromatography column modules |
| GB2485838A (en) | 2010-11-29 | 2012-05-30 | Ge Healthcare Bio Sciences Ab | Chromatography column |
| WO2012104278A1 (en) * | 2011-02-02 | 2012-08-09 | F. Hoffmann-La Roche Ag | Chromatography column support |
| WO2014053872A2 (en) | 2011-09-27 | 2014-04-10 | Bailey Daniel Michael | Chromatography column |
| US9943594B2 (en) | 2011-10-11 | 2018-04-17 | Sanofi Biotechnology | Methods for the treatment of rheumatoid arthritis |
| TWI589299B (zh) * | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
| CN202279403U (zh) * | 2011-10-12 | 2012-06-20 | 幸星(南京)数码有限公司 | 一种电路板用托盘 |
| US8941405B2 (en) * | 2012-08-03 | 2015-01-27 | International Business Machines Corporation | FET pair based physically unclonable function (PUF) circuit with a constant common mode voltage |
| TWI682780B (zh) | 2013-05-30 | 2020-01-21 | 美商再生元醫藥公司 | 醫藥組成物用於製造治療與ｐｃｓｋ９功能獲得性突變有關之體染色體顯性高膽固醇血症的藥物之用途 |
| US10111953B2 (en) * | 2013-05-30 | 2018-10-30 | Regeneron Pharmaceuticals, Inc. | Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9) |
| TWI755763B (zh) | 2013-06-04 | 2022-02-21 | 美商再生元醫藥公司 | 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 |
| US20150041381A1 (en) * | 2013-08-07 | 2015-02-12 | Pall Corporation | Chromatography column |
| CN203473605U (zh) * | 2013-09-24 | 2014-03-12 | 王佳胶带(上海松江）有限公司 | 胶带卷储放承载板结构 |
| JP6355640B2 (ja) * | 2013-09-30 | 2018-07-11 | 積水メディカル株式会社 | 収納容器に収納されたカラム及びカラム収納容器 |
| US9375657B2 (en) * | 2013-11-12 | 2016-06-28 | Orochem Technologies, Inc. | Flash chromatography column apparatus |
| CN203714436U (zh) * | 2013-12-27 | 2014-07-16 | 上海集成电路研发中心有限公司 | 硅片存储装置 |
| CN104150114B (zh) * | 2014-07-24 | 2017-02-01 | 陈浩能 | 一种包装盒 |
| WO2016089886A2 (en) | 2014-12-02 | 2016-06-09 | Regeneron Pharmaceuticals, Inc. | Methods for treating dry eye disease by administering an il-6r antagonist |
| JP2016173255A (ja) * | 2015-03-16 | 2016-09-29 | 株式会社島津製作所 | 液体クロマトグラフ装置 |
| CN204699732U (zh) | 2015-06-10 | 2015-10-14 | 中国农业科学院兰州畜牧与兽药研究所 | 一种色谱柱存放盒 |
| TW201709961A (zh) * | 2015-09-04 | 2017-03-16 | 益生生技開發股份有限公司 | 以奈米纖維建立之親和性層析法 |
| CN205879894U (zh) | 2016-06-30 | 2017-01-11 | 杭州泽天科技有限公司 | 色谱柱箱 |
| CN205902225U (zh) * | 2016-08-19 | 2017-01-18 | 潍坊歌尔电子有限公司 | 一种电路板载具 |
| CN206278415U (zh) * | 2016-12-09 | 2017-06-27 | 王佳胶带科技(南通)有限公司 | 胶带卷包装箱结构 |
| CN206444246U (zh) * | 2017-01-12 | 2017-08-29 | 浙江绍兴东灵保健食品有限公司 | 一种层析柱 |
| CN206543430U (zh) * | 2017-03-10 | 2017-10-10 | 黄山学院 | 一种多道流程加热的黄曲霉毒素免疫亲和柱 |
| CN206719956U (zh) * | 2017-05-09 | 2017-12-08 | 蓝思科技（长沙）有限公司 | 一种玻璃平板产品包装结构 |
| CN117405806A (zh) * | 2017-12-13 | 2024-01-16 | 里珍纳龙药品有限公司 | 管理层析柱床支架的装置和系统及相关方法 |
-
2018
- 2018-11-29 CN CN202311502458.2A patent/CN117405806A/zh active Pending
- 2018-11-29 IL IL313285A patent/IL313285B2/en unknown
- 2018-11-29 KR KR1020207019692A patent/KR102751947B1/ko active Active
- 2018-11-29 JP JP2020530621A patent/JP7171724B2/ja active Active
- 2018-11-29 IL IL319165A patent/IL319165A/en unknown
- 2018-11-29 CN CN201880078659.5A patent/CN111465848B/zh active Active
- 2018-11-29 IL IL296138A patent/IL296138B2/en unknown
- 2018-11-29 EA EA202091436A patent/EA039731B1/ru unknown
- 2018-11-29 AU AU2018385394A patent/AU2018385394B2/en active Active
- 2018-11-29 IL IL275125A patent/IL275125B2/en unknown
- 2018-11-29 CA CA3084155A patent/CA3084155A1/en active Pending
- 2018-11-29 EP EP18821837.4A patent/EP3724653B1/en active Active
- 2018-11-29 KR KR1020257000236A patent/KR20250009014A/ko active Pending
- 2018-11-29 MX MX2020005699A patent/MX2020005699A/es unknown
- 2018-11-29 SG SG11202005154VA patent/SG11202005154VA/en unknown
- 2018-11-29 US US16/204,225 patent/US11460452B2/en active Active
- 2018-11-29 WO PCT/US2018/063029 patent/WO2019118187A1/en not_active Ceased
- 2018-12-05 TW TW111133769A patent/TWI806758B/zh active
- 2018-12-05 TW TW107143541A patent/TWI791073B/zh active
- 2018-12-05 TW TW112118374A patent/TWI864762B/zh active
- 2018-12-11 AR ARP180103615A patent/AR113632A1/es active IP Right Grant
-
2020
- 2020-07-13 MX MX2024013981A patent/MX2024013981A/es unknown
- 2020-07-13 MX MX2024013982A patent/MX2024013982A/es unknown
-
2022
- 2022-05-24 AR ARP220101379A patent/AR125965A2/es active IP Right Grant
- 2022-08-15 US US17/819,720 patent/US11971393B2/en active Active
- 2022-11-02 JP JP2022176287A patent/JP7450005B2/ja active Active
-
2024
- 2024-03-04 JP JP2024032241A patent/JP7693042B2/ja active Active
- 2024-03-28 US US18/619,865 patent/US12510521B2/en active Active
- 2024-07-29 AU AU2024205167A patent/AU2024205167B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120279034A1 (en) * | 2009-12-17 | 2012-11-08 | Ge Healthcare Bio-Sciences Ab | Chromatography column and maintenance method |
| US8343349B2 (en) * | 2009-12-17 | 2013-01-01 | Ge Healthcare Bio-Sciences Ab | Chromatography column and maintenance method |
| CN104364645A (zh) * | 2012-06-21 | 2015-02-18 | 通用电气健康护理生物科学股份公司 | 色谱柱和对色谱柱进行维护的方法 |
| CN104307207A (zh) * | 2013-12-17 | 2015-01-28 | 长沙市源创精科生物技术有限公司 | 一种全自动层析柱 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7693042B2 (ja) | クロマトグラフィーカラム床支持体を特定のクロマトグラフィー操作の専用にする方法 | |
| US11642455B2 (en) | Instruments and methods for loading cells into implantable devices | |
| US9315774B2 (en) | Device for the aseptic expansion of cells | |
| BR122024016307B1 (pt) | Estojo de suporte de leito de coluna cromatográfica | |
| BR122022018081B1 (pt) | Método para dedicar um par de suportes de coluna cromatográfica a uma operação específica cromatográfica | |
| BR112020011072B1 (pt) | Estojos de suporte de leito de coluna cromatográfica, sistema de armazenamento de suporte de leito de coluna de cromatografia e método para armazenar um suporte de leito de coluna cromatográfica | |
| BR122024016307A2 (pt) | Estojo de suporte de leito de coluna cromatográfica, sistema de armazenamento de suporte de leito de coluna cromatográfica e método para armazenar suporte de leito de coluna cromatográfica | |
| HK40030214A (en) | Devices and systems for chromatography column bed support management and related methods | |
| HK40030214B (en) | Devices and systems for chromatography column bed support management and related methods | |
| EA046256B1 (ru) | Устройства и системы для управления опорой слоя сорбента хроматографической колонки и связанные с ними способы | |
| EA050891B1 (ru) | Устройства и системы для управления опорой слоя сорбента хроматографической колонки и связанные с ними способы |